Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
BMC Pulm Med ; 22(1): 283, 2022 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-35870927

RESUMO

BACKGROUND: The global prevalence and incidence of nontuberculous mycobacteria (NTM) infection are increasing. However, the prevalence of NTM infection-associated comorbidities remains understudied. Thus, we investigated the comorbidities associated with NTM infection using the National Health Insurance Service-National Sample Cohort (NHIS-NSC) 2.0 database of the National Health Insurance Service (NHIS). METHODS: In this case-control study, patients with NTM infection and controls aged 20-89 years of age were matched 1:4 by sex, age, region, and income. A total of 26 comorbidities were selected based on previous reports and claims data analysis. The distribution of comorbidities was compared between patients with NTM infection and controls by sex and age using logistic regression analysis. RESULTS: In total, 893 patients (379 men and 514 women) with NTM infection (mean age, 56.1 years) and 3,572 controls (mean age, 55.6 years) were included. The odds ratio for prevalence of respiratory diseases, metabolic diseases, musculoskeletal disorders, gastrointestinal diseases, skin diseases, mental diseases, and neoplasms was significantly higher in patients with NTM infection than in the control group. Among comorbid diseases, the odds ratios (ORs) for the prevalence of the respiratory diseases such as bronchiectasis (OR [95% confidence interval (CI)]: 26.79 [19.69-36.45]) and interstitial pneumonitis (OR [95% CI]: 15.10 [7.15-31.89]) were the highest. No significant differences were observed in NTM infection-related comorbidities between men and women. In the younger age group (20-39 years old), the prevalence of respiratory and systemic diseases such as hypertension and diabetes was higher in the patient group than in the control group. CONCLUSIONS: NTM infection is associated with several respiratory and systemic diseases that should be considered when providing medical care to patients with NTM infection.


Assuntos
Infecções por Mycobacterium não Tuberculosas , Micobactérias não Tuberculosas , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/complicações , Programas Nacionais de Saúde , República da Coreia/epidemiologia , Adulto Jovem
2.
J Infect Chemother ; 26(2): 300-304, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31859040

RESUMO

There have been no case reports of thoracic subcutaneous abscess after surgery for Mycobacterium abscessus complex associated empyema. We herein report a case of Mycobacterium abscessus subsp. abscessus (M. abscessus subsp. abscessus) induced subcutaneous abscesses following surgical treatment for concurrent M. abscessus subsp. abscessus -associated empyema and pneumothorax. A 75-year-old woman had M. abscessus subsp. abscessus -associated empyema and pneumothorax. She underwent surgical treatment of decortication and fistulectomy and suffered from M. abscessus subsp. abscessus -associated subcutaneous abscesses after thoracentesis/drainage. A multidisciplinary approach combined with surgical care, thermal therapy, and multidrug chemotherapy contributed to a successful result. An early multidisciplinary approach is believed to be important in cases of M. abscessus subsp. abscessus -associated empyema and subcutaneous abscess.


Assuntos
Abscesso/microbiologia , Empiema Pleural/microbiologia , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium abscessus/isolamento & purificação , Tela Subcutânea/patologia , Abscesso/diagnóstico , Abscesso/terapia , Idoso , Antibacterianos/uso terapêutico , Empiema Pleural/complicações , Empiema Pleural/diagnóstico , Empiema Pleural/tratamento farmacológico , Feminino , Humanos , Hipertermia Induzida/métodos , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Pneumotórax/complicações , Pneumotórax/diagnóstico , Pneumotórax/microbiologia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/microbiologia , Tela Subcutânea/microbiologia , Tórax/diagnóstico por imagem , Tórax/patologia , Tomografia Computadorizada por Raios X , Resultado do Tratamento
3.
Paediatr Respir Rev ; 33: 45-51, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30962152

RESUMO

OBJECTIVES: To describe the clinical-radiological-pathological characteristics and treatment outcomes of children with suspected exogenous lipoid pneumonia (ELP). DESIGN: Systematic review. We searched electronic databases and reference lists published between 1967 and 2018, restricted to non-accidental cases. RESULTS: Forty-four studies including 489 participants aged 1 day to 17 years from 13 countries were included. Cultural, medical, and behavioural rationale for oil-use was described. The clinical-radiological presentation varied widely. Diagnostic certainty was deemed highest if ELP was confirmed on bronchoalveolar lavage/frozen section lung biopsy with documented extracellular lipid on cytological staining and/or fat analysis. Non-tuberculous mycobacteria infection was identified in six studies: Mycobacterium fortuitum/chelonei, Mycobacterium smegmatis and Mycobacterium abscessus. Treatment comprised supportive therapy, corticosteroids, stopping oil, therapeutic lung-lavage and surgical resection. Outcomes were reported inconsistently. CONCLUSION: Paediatric ELP resulting from cultural and medical practices continues to be described globally. Preventive interventions, standardized reporting, and treatment efficacy studies for cases not averted, are lacking. Protocol registration: PROSPERO CRD42017068313.


Assuntos
Cultura , Óleos/efeitos adversos , Pneumonia Lipoide/etiologia , Corticosteroides/uso terapêutico , Antibacterianos/uso terapêutico , Biópsia , Lavagem Broncoalveolar , Dor no Peito , Criança , Constipação Intestinal/terapia , Tosse , Suplementos Nutricionais , Humanos , Hipóxia , Laxantes/uso terapêutico , Antissépticos Bucais/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/complicações , Lavagem Nasal , Óleos/uso terapêutico , Osteoartropatia Hipertrófica Primária , Oxigenoterapia , Cuidados Paliativos , Pneumonia Bacteriana/complicações , Pneumonia Lipoide/diagnóstico por imagem , Pneumonia Lipoide/microbiologia , Pneumonia Lipoide/terapia , Pneumonia Viral/complicações , Respiração Artificial , Fatores de Risco , Taquipneia , Tuberculose Pulmonar/complicações
4.
Transpl Infect Dis ; 19(1)2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27775824

RESUMO

Nontuberculous mycobacterial infections can often occur in individuals with adequate immune function. Such infections typically have cutaneous involvement and are caused by rapidly growing mycobacterium. Other nontuberculous mycobacteria species, like Mycobacterium haemophilum, almost always present as opportunistic infections occurring in severely immunocompromised hosts. Here, we present a complicated and protracted course of diagnosing M. haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient.


Assuntos
Antibacterianos/uso terapêutico , Celulite (Flegmão)/tratamento farmacológico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Leucemia Mieloide Aguda/cirurgia , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium haemophilum/isolamento & purificação , Infecções Oportunistas/tratamento farmacológico , Biópsia , Celulite (Flegmão)/complicações , Celulite (Flegmão)/diagnóstico , Celulite (Flegmão)/microbiologia , Ciprofloxacina/uso terapêutico , Claritromicina/uso terapêutico , Feminino , Doença Enxerto-Hospedeiro/diagnóstico , Doença Enxerto-Hospedeiro/tratamento farmacológico , Humanos , Hospedeiro Imunocomprometido , Terapia de Imunossupressão/efeitos adversos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Extremidade Inferior , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Infecções por Mycobacterium não Tuberculosas/microbiologia , Infecções Oportunistas/complicações , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/microbiologia , Rifabutina/uso terapêutico , Tacrolimo/efeitos adversos , Tacrolimo/uso terapêutico , Doadores não Relacionados
5.
Orthopedics ; 34(12): e952-5, 2011 Dec 06.
Artigo em Inglês | MEDLINE | ID: mdl-22146217

RESUMO

Mycobacterium other than tuberculosis infections rarely develop in healthy individuals, but direct inoculation such as contaminated acupuncture can cause mycobacteriosis even in an immunocompetent host. A 56-year-old woman gradually developed pain on the anterior aspect of the left knee and the distal thigh after hiking without trauma. She received acupuncture for 3 consecutive days on the bilateral knees at the suprapatellar and infrapopliteal areas. After acupuncture, mild localized heat and painful swelling developed around the knees bilaterally. Magnetic resonance imaging (MRI) demonstrated soft tissue masses with a lobulated contour at the prefemoral fat between the suprapatellar pouch and the distal femur and at the proximal tibia behind the knee joint capsule. Fibromatosis, pigmented villonodular synovitis, and soft tissue sarcoma were considered. On pathologic examination, multiple granulomas with lymphoplasmatic infiltration were evident, and acid-fast bacteria staining revealed acid-fast bacilli. A mycobacterial culture confirmed Mycobacterium other than tuberculosis infection, and a polymerase chain reaction-fragment length polymorphism assay identified the isolates as Mycobacterium abscessus. After treatment with appropriate antibiotics, the patient had no evidence of disease and reported no pain during activities of daily living. Acupuncture is growing in prominence in Europe and the United States, and the number of reports on complications increases with its widespread use. Although the risk to an individual patient is difficult to determine, acupuncture may cause serious complications in patients with coagulopathy, heart valve disease, and immune deficiency. In addition, direct inoculation such as contaminated acupuncture can cause mycobacteriosis even in an immunocompetent host.


Assuntos
Terapia por Acupuntura/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Micobactérias não Tuberculosas/isolamento & purificação , Neoplasias de Tecidos Moles/diagnóstico , Atividades Cotidianas , Antibacterianos/uso terapêutico , Diagnóstico Diferencial , Feminino , Humanos , Imunocompetência , Articulação do Joelho/microbiologia , Articulação do Joelho/patologia , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Dor/etiologia , Dor/patologia , Manejo da Dor , Resultado do Tratamento
6.
Rev Med Liege ; 64(7-8): 390-3, 2009.
Artigo em Francês | MEDLINE | ID: mdl-19777918

RESUMO

We report the case of a 57-year-old patient in whom we found a pulmonary infection due to Mycobacterium malmoense. This patient had no immunodeficiency and responded quite rapidly to anti-tuberculous therapy. He was treated for 6 months by levofloxacine, myambutol, and nicotibine, followed by 3 months of clarithromycine, levofloxacine and myambutol. The patient improved clinically to become asymptomatic and the cavitary lesion shown at the CT-scan slightly decreased. The patient is still currently treated by clarithromycine and ciproxine.


Assuntos
Antibacterianos/uso terapêutico , Imunocompetência , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Micobactérias não Tuberculosas/isolamento & purificação , Pneumonia Bacteriana/tratamento farmacológico , Pneumonia Bacteriana/microbiologia , Antituberculosos/uso terapêutico , Ciprofloxacina/uso terapêutico , Claritromicina/uso terapêutico , Combinação de Medicamentos , Quimioterapia Combinada , Etambutol/uso terapêutico , Humanos , Hidrocortisona/uso terapêutico , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Ofloxacino/uso terapêutico , Pneumonia Bacteriana/diagnóstico , Resultado do Tratamento , Complexo Vitamínico B/uso terapêutico
7.
Thorax ; 51(12): 1248-52, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8994524

RESUMO

BACKGROUND: In the United Kingdom Mycobacterium kansasii is the most common pulmonary non-tuberculous mycobacteria to cause disease in the non-HIV positive population. METHODS: The clinical features, treatment, and outcome of 47 patients (13 women) of mean (SD) age 58 (17) years with culture positive pulmonary M kansasii infection were compared with those of 87 patients (23 women) of mean (SD) age 57 (16) years with culture positive pulmonary M tuberculosis infection by review of their clinical and laboratory records. Each patient with M kansasii infection was matched for age, sex, race and, where possible, year of diagnosis with two patients with M tuberculosis infection. RESULTS: All those with M kansasii infection were of white race. Haemoptysis was more common in patients infected with M kansasii but they were less likely to present as a result of an incidental chest radiograph or symptoms other than those due to mycobacterial infection. Patients with M kansasii were also less likely to have a history of diabetes, but the frequency of previous chest disease and tuberculosis was similar. An alcohol intake of > 14 units/week was less frequent in those with M kansasii, but there were no significant differences in drug history, past and present smoking habit, occupational exposures, social class, or marital status. Patients with M kansasii received a longer total course of antimycobacterial therapy and, in particular, extended treatment with ethambutol and rifampicin was given. There was no significant difference in outcome between pulmonary M kansasii or M tuberculosis infection. CONCLUSIONS: There are group differences between the clinical features of the two infections but, with the possible exception of diabetes and alcohol intake, these features are unlikely to be diagnostically helpful. Treatment of M kansasii infection with ethambutol, isoniazid, and rifampicin in these patients was as effective as standard regimens given to patients infected with M tuberculosis.


Assuntos
Antituberculosos/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/fisiopatologia , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/fisiopatologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Causas de Morte , Etambutol/uso terapêutico , Feminino , Seguimentos , Hemoptise/complicações , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/complicações , Rifampina/uso terapêutico , Fatores de Risco , Análise de Sobrevida , Fatores de Tempo , Resultado do Tratamento , Tuberculose Pulmonar/complicações
8.
J Clin Pathol ; 49(10): 821-3, 1996 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8943748

RESUMO

AIM: To report the clinical significance and treatment of Mycobacterium kansasii infection in the context of HIV disease. DESIGN/METHODS: Retrospective case review of all isolates of M kansasii until June 1994. RESULTS: Ten cases of M kansasii were isolated. All but one patient with this infection had clinical symptoms compatible with generalised infection. The majority had chest infections with the organism isolated on induced sputum but not routine sputum. All isolates were sensitive to ethambutol and nine of 10 to rifampicin. All isolates were resistant to isoniazid and pyrazinamide. CONCLUSION: M kansasii is a pathogen in HIV infected patients and should be treated when isolated. Treatment should be with rifampicin and ethambutol but not isoniazid, as has been recommended previously.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS , Infecções por HIV/complicações , Infecções por Mycobacterium não Tuberculosas/complicações , Micobactérias não Tuberculosas/isolamento & purificação , Quimioterapia Combinada , Humanos , Testes de Sensibilidade Microbiana , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/patologia , Estudos Retrospectivos
9.
Recenti Prog Med ; 85(11): 526-36, 1994 Nov.
Artigo em Italiano | MEDLINE | ID: mdl-7855386

RESUMO

Digestive apparatus is a common target of atypical mycobacteriosis in AIDS patients (at least 50% of patients with CD4+ lymphocytes < 50/mm3). We describe the clinical-histological features of two cases of Whipple-like syndrome likely caused by Mycobacterium avium (MAI) (study performed by light and electron microscopy), of one case of infection caused by two morphological variants of a MAI strain with a different sensitivity to antibiotics, of one case of M. kansasii infection and of two cases of M. genavense infection accompanied by sensitivity tests to antibiotics (as far as we know, these are the first described quantitative sensitivity tests of M. genavense to antibiotics). In conclusion, we discuss the present therapeutical outlines for M. kansasii and avium, together with the teramporary pharmacological options for M. genavense as suggested by antibiotic sensitivity tests performed on the strains isolated from the studied patients.


Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Antituberculosos/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium avium , Tuberculose Gastrointestinal/tratamento farmacológico , Adulto , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Infecções por Mycobacterium não Tuberculosas/complicações , Tuberculose Gastrointestinal/complicações
10.
Br J Dermatol ; 131(3): 376-9, 1994 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7918014

RESUMO

A patient with rheumatoid arthritis developed ulcerated nodules predominantly on his legs. Skin biopsy and culture demonstrated rheumatoid vasculitis and infection with Mycobacterium haemophilum. Improvement was not seen until clarithromycin was added to his treatment regimen.


Assuntos
Quimioterapia Combinada/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Idoso , Artrite Reumatoide/complicações , Ciprofloxacina/uso terapêutico , Claritromicina/uso terapêutico , Humanos , Masculino , Infecções por Mycobacterium não Tuberculosas/complicações , Infecções por Mycobacterium não Tuberculosas/patologia , Prednisona/uso terapêutico , Rifampina/uso terapêutico , Pele/patologia , Vasculite/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA